COVID-19 Impact on Global Antiviral Drugs Market

1. Antiviral Drugs Market Size & Analysis - Forecast to 2026 As per the research conducted by GME, the Antiviral Drugs market will grow with a CAGR value of 2.3 percent by 2026. The variables driving the development of the antiviral drugs market are the increasing susceptible populace of infectious diseases including respiratory syncytial virus and flu, as well as the widespread use of antiviral medications. The key drivers of this overall market expansion are evolving antiviral drug markets and massive spending in research and development. Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Antiviral Drugs Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-antiviral-drugs-market-3096 By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, and Others), By Application (HIV, Herpes, Hepatitis, Influenza, and Others), By Type (Branded and Generic), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); Company Market Share Analysis, End-User Landscape, and Competitor Analysis. Key Market Insights Innovations in formulation, including fixed-dose conjunction, and a growing market for disease- specific therapy are some of the reasons influencing the antiviral medication market. Depending on the drug class,the reverse transcriptase inhibitors segment is leading dueto their accessibility and minimal biological impediments. Due to the current exponential increase in the proliferation of HIV infection globally, the HIV segment accounted for the largest market share. The branded antiviral drugis the dominating segment owing to its global market presence and acceptance. North America is dominating this market owing to the highest number of cases of various viral diseases. Gilead Sciences, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, AbbVie, Merck & Co., Inc., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Cipla Inc., Aurobindo Pharma, and Dr. Reddy’s Laboratories Ltd. among others, are the top players in the antiviral drugs market. Browse the Report @ https://www.globalmarketestimates.com/market-report/global-antiviral-drugs-market- 3096 Drug Class Outlook (Revenue, USD Billion, 2021-2026)

2. DNA Polymerase Inhibitors Reverse Transcriptase Inhibitors Protease Inhibitors Neuraminidase Inhibitors Application (Revenue, USD Billion, 2021-2026) HIV Herpes Hepatitis Influenza Others Type Outlook (Revenue, USD Billion, 2021-2026) Branded Generic Regional Outlook (Revenue, USD Billion, 2021-2026) North America The U.S. Canada Mexico Europe Germany UK France Spain Italy Rest of Europe Asia Pacific China

3. India Japan South Korea Australia Rest of APAC Central & South America Brazil Argentina Rest of CSA Middle East & Africa Saudi Arabia UAE Rest of MEA Contact: Tracy Simon Email address: tracy.simon@globalmarketestimates.com Phone Number: +16026667238 Website: https://www.globalmarketestimates.com/ Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php